Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 304

1.

Pyogenic bacterial lower respiratory tract infection in human immunodeficiency virus-infected patients.

Mayaud C, Parrot A, Cadranel J.

Eur Respir J Suppl. 2002 Jul;36:28s-39s. Review.

2.

Pneumonia in HIV-infected patients in the HAART era: incidence, risk, and impact of the pneumococcal vaccination.

López-Palomo C, Martín-Zamorano M, Benítez E, Fernández-Gutiérrez C, Guerrero F, Rodríguez-Iglesias M, Girón-González JA.

J Med Virol. 2004 Apr;72(4):517-24.

PMID:
14981752
3.

The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.

Nachman S, Gona P, Dankner W, Weinberg A, Yogev R, Gershon A, Rathore M, Read JS, Huang S, Elgie C, Hudgens K, Hughes W.

Pediatrics. 2005 Apr;115(4):e488-94. Epub 2005 Mar 16.

PMID:
15772172
5.

Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.

Madeddu G, Porqueddu EM, Cambosu F, Saba F, Fois AG, Pirina P, Mura MS.

Infection. 2008 Jun;36(3):231-6. doi: 10.1007/s15010-007-7162-0. Epub 2008 May 10.

PMID:
18463787
6.

Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.

Nesheim SR, Kapogiannis BG, Soe MM, Sullivan KM, Abrams E, Farley J, Palumbo P, Koenig LJ, Bulterys M.

Pediatrics. 2007 Jul;120(1):100-9.

PMID:
17606567
7.

Discontinuation of secondary prophylaxis for Pneumocystis pneumonia in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy.

Esposito S, Bojanin J, Porta A, Cesati L, Gualtieri L, Principi N.

Pediatr Infect Dis J. 2005 Dec;24(12):1117-20.

PMID:
16371882
9.

Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy.

Ylitalo N, Brogly S, Hughes MD, Nachman S, Dankner W, Van Dyke R, Seage GR 3rd; Pediatric AIDS Clincial Trials Group Protocol 219C Team.

Arch Pediatr Adolesc Med. 2006 Aug;160(8):778-87.

PMID:
16894075
10.

Remission of relapsing Pseudomonas aeruginosa bronchopulmonary infection following antiretroviral therapy.

Domingo P, Ferré A, Baraldès MA, Ris J, Sánchez F.

Arch Intern Med. 1998 Apr 27;158(8):929-30. No abstract available.

PMID:
9570185
11.

Bacterial community-acquired pneumonia in HIV-infected patients.

Madeddu G, Laura Fiori M, Stella Mura M.

Curr Opin Pulm Med. 2010 May;16(3):201-7. doi: 10.1097/MCP.0b013e3283375825. Review.

PMID:
20154625
12.

Intravenous immune globulin for prevention of bacterial infections in pediatric AIDS patients.

Crow ME.

Am J Health Syst Pharm. 1995 Apr 15;52(8):803-11. Review.

PMID:
7634115
13.

Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy.

Jordano Q, Falcó V, Almirante B, Planes AM, del Valle O, Ribera E, Len O, Pigrau C, Pahissa A.

Clin Infect Dis. 2004 Jun 1;38(11):1623-8. Epub 2004 May 12.

14.

Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a nationwide cohort study.

Weis N, Lindhardt BO, Kronborg G, Hansen AB, Laursen AL, Christensen PB, Nielsen H, Moller A, Sorensen HT, Obel N.

Clin Infect Dis. 2006 May 15;42(10):1481-7. Epub 2006 Apr 12.

15.

Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.

Bonnet F, Lewden C, May T, Heripret L, Jougla E, Bevilacqua S, Costagliola D, Salmon D, Chêne G, Morlat P.

Cancer. 2004 Jul 15;101(2):317-24.

16.

Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia.

Madec Y, Laureillard D, Pinoges L, Fernandez M, Prak N, Ngeth C, Moeung S, Song S, Balkan S, Ferradini L, Quillet C, Fontanet A.

AIDS. 2007 Jan 30;21(3):351-9.

PMID:
17255742
17.

Impact of tobacco use on the development of opportunistic respiratory infections in HIV seropositive patients on antiretroviral therapy.

Miguez-Burbano MJ, Burbano X, Ashkin D, Pitchenik A, Allan R, Pineda L, Rodriguez N, Shor-Posner G.

Addict Biol. 2003 Mar;8(1):39-43.

PMID:
12745414
18.

Improvement of symptomatic human immunodeficiency virus-related lymphoid interstitial pneumonia in patients receiving highly active antiretroviral therapy.

Dufour V, Wislez M, Bergot E, Mayaud C, Cadranel J.

Clin Infect Dis. 2003 May 15;36(10):e127-30. Epub 2003 May 6.

20.

Treatment of community-acquired lower respiratory tract infections during pregnancy.

Lim WS, Macfarlane JT, Colthorpe CL.

Am J Respir Med. 2003;2(3):221-33. Review.

PMID:
14720004
Items per page

Supplemental Content

Write to the Help Desk